CEI: A Clonal Expansion Identifier for T-cell receptor clones following SARS-CoV-2 vaccination
Yunbei Pan, Christian Hofmann, Barbara Banbury, Harsh Patel, Stephanie A. Bien, Tom Chou, Otto O. Yang

TL;DR
This paper introduces CEI, a statistical method to identify and quantify T-cell receptor clones that expand in response to SARS-CoV-2 vaccination, providing insights into immune dynamics.
Contribution
We developed a novel statistical approach to detect vaccine-associated TCR clones and demonstrated its effectiveness with real data from vaccinated individuals.
Findings
Successfully identified vaccine-responsive TCR clones in peripheral blood.
Quantified clone-specific T-cell abundance changes post-vaccination.
Validated the method's robustness in vivo.
Abstract
Each T cell typically carries a specific T-cell receptor (TCR) that determines its specificity against an epitope presented by the HLA complex on a target cell. Antigenic challenge triggers the expansion of reactive cells within a diverse pool of T cells with randomly generated receptors, a process that results in epitope-driven shifts of TCR frequencies over time. Here, we analyze the effects of SARS-CoV-2 vaccination on the TCR populations in peripheral blood drawn from seven COVID-naive individuals, before vaccines were widely available. To identify SARS-CoV-2 vaccine-associated TCR sequences among the TCR sequences sampled before and after vaccination, we develop statistical criteria to detect significant increases in abundance of positive TCR clones. Application of our statistical methods shows a robust identification of TCR sequences that respond to SARS-CoV-2…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
Topicsvaccines and immunoinformatics approaches · T-cell and B-cell Immunology · SARS-CoV-2 and COVID-19 Research
